Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
5367 | 1565 | 43.2 | 89% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
392 | 16284 | LONG QT SYNDROME//BRUGADA SYNDROME//QT INTERVAL |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HERG | Author keyword | 236 | 54% | 19% | 305 |
2 | HUMAN ETHER A GO GO RELATED GENE | Author keyword | 102 | 81% | 4% | 61 |
3 | HERG CHANNEL | Author keyword | 56 | 62% | 4% | 58 |
4 | RAPID DELAYED RECTIFIER | Author keyword | 52 | 100% | 1% | 18 |
5 | I KR | Author keyword | 31 | 46% | 3% | 50 |
6 | ETHER A GO GO | Author keyword | 29 | 77% | 1% | 20 |
7 | HUMAN ETHER A GO GO RELATED GENE HERG | Author keyword | 27 | 83% | 1% | 15 |
8 | HERG POTASSIUM CHANNEL | Author keyword | 21 | 73% | 1% | 16 |
9 | EAG1 | Author keyword | 19 | 80% | 1% | 12 |
10 | HERG CHANNELS | Author keyword | 19 | 74% | 1% | 14 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HERG | 236 | 54% | 19% | 305 | Search HERG | Search HERG |
2 | HUMAN ETHER A GO GO RELATED GENE | 102 | 81% | 4% | 61 | Search HUMAN+ETHER+A+GO+GO+RELATED+GENE | Search HUMAN+ETHER+A+GO+GO+RELATED+GENE |
3 | HERG CHANNEL | 56 | 62% | 4% | 58 | Search HERG+CHANNEL | Search HERG+CHANNEL |
4 | RAPID DELAYED RECTIFIER | 52 | 100% | 1% | 18 | Search RAPID+DELAYED+RECTIFIER | Search RAPID+DELAYED+RECTIFIER |
5 | I KR | 31 | 46% | 3% | 50 | Search I+KR | Search I+KR |
6 | ETHER A GO GO | 29 | 77% | 1% | 20 | Search ETHER+A+GO+GO | Search ETHER+A+GO+GO |
7 | HUMAN ETHER A GO GO RELATED GENE HERG | 27 | 83% | 1% | 15 | Search HUMAN+ETHER+A+GO+GO+RELATED+GENE+HERG | Search HUMAN+ETHER+A+GO+GO+RELATED+GENE+HERG |
8 | HERG POTASSIUM CHANNEL | 21 | 73% | 1% | 16 | Search HERG+POTASSIUM+CHANNEL | Search HERG+POTASSIUM+CHANNEL |
9 | EAG1 | 19 | 80% | 1% | 12 | Search EAG1 | Search EAG1 |
10 | HERG CHANNELS | 19 | 74% | 1% | 14 | Search HERG+CHANNELS | Search HERG+CHANNELS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HUMAN INWARD RECTIFIER | 215 | 86% | 7% | 108 |
2 | CARDIAC ARRHYTHMIA | 175 | 37% | 25% | 384 |
3 | I KR | 164 | 52% | 14% | 223 |
4 | DOFETILIDE BLOCK | 62 | 92% | 2% | 24 |
5 | LONG QT SYNDROME | 61 | 12% | 31% | 492 |
6 | HERG | 55 | 27% | 11% | 179 |
7 | GENE POTASSIUM CHANNEL | 48 | 91% | 1% | 20 |
8 | 1 3 BIS 2 HYDROXY 5 TRIFLUOROMETHYL PHENYL UREA NS1643 | 44 | 100% | 1% | 16 |
9 | HERG POTASSIUM CHANNEL | 44 | 61% | 3% | 47 |
10 | HUMAN ETHER | 44 | 85% | 1% | 23 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The Enigmatic Cytoplasmic Regions of KCNH Channels | 2015 | 2 | 81 | 75% |
hERG K+ CHANNELS: STRUCTURE, FUNCTION, AND CLINICAL SIGNIFICANCE | 2012 | 83 | 645 | 57% |
hERG potassium channels and cardiac arrhythmia | 2006 | 583 | 83 | 55% |
The roles of K+ channels in cancer | 2014 | 26 | 151 | 38% |
Potassium channels in cell cycle and cell proliferation | 2014 | 19 | 115 | 40% |
Recent Developments in Computational Prediction of hERG Blockage | 2013 | 11 | 95 | 89% |
Novel roles for hERG K+ channels in cell proliferation and apoptosis | 2011 | 42 | 70 | 63% |
An introduction to QT interval prolongation and non-clinical approaches to assessing and reducing risk | 2010 | 53 | 34 | 59% |
Voltage-gated potassium channels as therapeutic targets | 2009 | 212 | 232 | 22% |
The hERG potassium channel and hERG screening for drug-induced torsades de pointes | 2008 | 78 | 210 | 61% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MARK COWLEY LIDWILL PROGRAM CARDIAC ELE OPH | 14 | 100% | 0.4% | 7 |
2 | QT PRODACT | 8 | 70% | 0.4% | 7 |
3 | ONCOPHYSIOL GRP | 8 | 100% | 0.3% | 5 |
4 | MOL CARDIOL BIOPHYS | 4 | 32% | 0.7% | 11 |
5 | NORA ECCLES HARRISON CARDIOVASC TRAINING IN | 4 | 13% | 1.9% | 30 |
6 | MOL BIOL NEURONAL SIGNALS | 4 | 20% | 1.2% | 18 |
7 | ARBEITSGRP MOL ZELLULARE BIOPHYS | 3 | 45% | 0.3% | 5 |
8 | ECCLES PROGRAM HUMAN MOL BIOL GENET | 3 | 21% | 0.8% | 12 |
9 | EMERGING FIELD PHARMACOINFORMAT | 3 | 60% | 0.2% | 3 |
10 | JHICC | 2 | 44% | 0.3% | 4 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000248069 | PLANAR PATCH CLAMP//PLANAR PATCH CLAMP CHIP//CHANNEL RHODOPSIN |
2 | 0.0000213315 | TORSADES DE POINTES//TORSADE DE POINTES//ELECT ENGN CYBERNET |
3 | 0.0000203004 | LONG QT SYNDROME//KCNQ1//SHORT QT SYNDROME |
4 | 0.0000122173 | DOFETILIDE//MS 551//SOTALOL |
5 | 0.0000113751 | SERTINDOLE//PSYCHOPHARMACOL VENTURE//TROP TOXINOL UNIT |
6 | 0.0000112218 | KCSA//EPISODIC ATAXIA TYPE 1//MOL NEUROBIOL BIOPHYS |
7 | 0.0000100721 | KV13//KCA31//KV13 CHANNEL |
8 | 0.0000075273 | TRANSIENT OUTWARD CURRENT//KCHIP//KV42 |
9 | 0.0000065154 | CISAPRIDE//KW 5092//CINITAPRIDE |
10 | 0.0000056015 | QT DISPERSION//QT INTERVAL//THOROUGH QT STUDY |